4.7 Article

Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space

期刊

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 12, 期 6, 页码 3740-3756

出版社

MDPI AG
DOI: 10.3390/ijms12063740

关键词

chemokine; sulfotyrosine; NMR; structure; alignment; drug discovery

资金

  1. NIH [AI058072, AI063325, 1R15CA159202-01]
  2. State of Wisconsin Cancer Research Grant
  3. New England Division
  4. UWW

向作者/读者索取更多资源

Chemokine signaling is a well-known agent of autoimmune disease, HIV infection, and cancer. Drug discovery efforts for these signaling molecules have focused on developing inhibitors targeting their associated G protein-coupled receptors. Recently, we used a structure-based approach directed at the sulfotyrosine-binding pocket of the chemokine CXCL12, and thereby demonstrated that small molecule inhibitors acting upon the chemokine ligand form an alternative therapeutic avenue. Although the 50 members of the chemokine family share varying degrees of sequence homology (some as little as 20%), all members retain the canonical chemokine fold. Here we show that an equivalent sulfotyrosine-binding pocket appears to be conserved across the chemokine superfamily. We monitored sulfotyrosine binding to four representative chemokines by NMR. The results suggest that most chemokines harbor a sulfotyrosine recognition site analogous to the cleft on CXCL12 that binds sulfotyrosine 21 of the receptor CXCR4. Rational drug discovery efforts targeting these sites may be useful in the development of specific as well as broad-spectrum chemokine inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据